Sfoglia per Rivista CANCER RESEARCH
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer
2007-01-01 De Falco, V; Guarino, V; Avilla, E; Castellone, Md; Salerno, P; Salvatore, G; Faviana, P; Basolo, F; Santoro, M; Melillo, Rm.
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma
2007-01-01 Salvatore, Giuliana; Nappi, Tc; Salerno, P; Jiang, Y; Garbi, C; Ugolini, ; Miccoli, P; Basolo, F; Castellone, Md; A., CIRAFICI AM; Melillo, Rm; Fusco, ; Bittner, M; Santoro, M.
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype
1997-01-01 Carlomagno, F; Salvatore, Giuliana; Cirafici, Am; DE VITA, G; Melillo, Rm; DE FRANCISCIS, V; Billaud, M; Fusco, A; Santoro, M.
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer
2005-01-01 Rostn, G; Costa, Am; Pereiracastro, I; Salvatore, Giuliana; Moreira, S; Hernandez, R; Herrero, A; Fusco, A; Teijeiro, J; Santoro, M.
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma
2009-01-01 Nappi, Tc; Salerno, P; Zitzelsberger, H; Carlomagno, F; Salvatore, Giuliana; Santoro, M.
Oncogenic properties of the antisense lncRNA COMET in BRAF- and RET-driven papillary thyroid carcinomas
2019-01-01 Esposito, R.; Esposito, D.; Pallante, P.; Fusco, A.; Ciccodicola, A.; Costa, V.
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells
2004-01-01 Vitagliano, D; Carlomagno, F; Motti, Maria Letizia; Viglietto, G; Nikiforov, Ye; Nikiforova, Mn; Hershman, Jm; Ryan, Aj; Fusco, A; Melillo, Rm; Santoro, M.
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells
2008-01-01 Tazzari, P. L.; G., Tabellini; F., Ricci; Papa, V.; R., Bortul; F., Chiarini; C., Evangelisti; G., Martinelli; A., Bontadini; L., Cocco; Mccubrey, J. A.; Martelli, A. M.
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation
2007-01-01 Follo, My; Mongiorgi, S; Bosi, C; A., Cappellini; Finelli, C; Chiarini, F; Papa, V; Libra, M; Martinelli, G; Cocco, L; Martelli, Am
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer | 1-gen-2007 | De Falco, V; Guarino, V; Avilla, E; Castellone, Md; Salerno, P; Salvatore, G; Faviana, P; Basolo, F; Santoro, M; Melillo, Rm. | |
| A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma | 1-gen-2007 | Salvatore, Giuliana; Nappi, Tc; Salerno, P; Jiang, Y; Garbi, C; Ugolini, ; Miccoli, P; Basolo, F; Castellone, Md; A., CIRAFICI AM; Melillo, Rm; Fusco, ; Bittner, M; Santoro, M. | |
| The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype | 1-gen-1997 | Carlomagno, F; Salvatore, Giuliana; Cirafici, Am; DE VITA, G; Melillo, Rm; DE FRANCISCIS, V; Billaud, M; Fusco, A; Santoro, M. | |
| Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer | 1-gen-2005 | Rostn, G; Costa, Am; Pereiracastro, I; Salvatore, Giuliana; Moreira, S; Hernandez, R; Herrero, A; Fusco, A; Teijeiro, J; Santoro, M. | |
| Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma | 1-gen-2009 | Nappi, Tc; Salerno, P; Zitzelsberger, H; Carlomagno, F; Salvatore, Giuliana; Santoro, M. | |
| Oncogenic properties of the antisense lncRNA COMET in BRAF- and RET-driven papillary thyroid carcinomas | 1-gen-2019 | Esposito, R.; Esposito, D.; Pallante, P.; Fusco, A.; Ciccodicola, A.; Costa, V. | |
| Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells | 1-gen-2004 | Vitagliano, D; Carlomagno, F; Motti, Maria Letizia; Viglietto, G; Nikiforov, Ye; Nikiforova, Mn; Hershman, Jm; Ryan, Aj; Fusco, A; Melillo, Rm; Santoro, M. | |
| Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells | 1-gen-2008 | Tazzari, P. L.; G., Tabellini; F., Ricci; Papa, V.; R., Bortul; F., Chiarini; C., Evangelisti; G., Martinelli; A., Bontadini; L., Cocco; Mccubrey, J. A.; Martelli, A. M. | |
| The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation | 1-gen-2007 | Follo, My; Mongiorgi, S; Bosi, C; A., Cappellini; Finelli, C; Chiarini, F; Papa, V; Libra, M; Martinelli, G; Cocco, L; Martelli, Am |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile